Predicting therapeutic value in the lead optimization phase of drug discovery
- 1 June 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (6) , 429-438
- https://doi.org/10.1038/nrd1110
Abstract
Recombinant and natural cellular assays for human G-protein-coupled receptors are used to optimize initial lead molecules obtained from screening. Although the activity of these molecules can be assessed on human genotype receptors, there is increasing evidence that cells impose a phenotypic selectivity to molecules in various cellular backgrounds. This opens the possibility of dissimulations between activity seen in lead optimization assays and the intended therapeutic value in humans. This review discusses the mechanisms by which cells can impose phenotypic selectivity on molecules and approaches to reduce this practical problem for drug discovery.Keywords
This publication has 79 references indexed in Scilit:
- Characterization and Comparison of RGS2 and RGS4 as GTPase-Activating Proteins for m2 Muscarinic Receptor-Stimulated GiMolecular Pharmacology, 2002
- Phenotypic Changes of Adrenomedullin Receptor Components, RAMP2, and CRLR mRNA Expression in Cultured Rat Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2001
- Agonist trafficking of Gi/o‐mediated α2A‐adrenoceptor responses in HEL 92.1.7 cellsBritish Journal of Pharmacology, 2001
- Spontaneous Human B2 Bradykinin Receptor Activity Determines the Action of Partial Agonists as Agonists or Inverse AgonistsJournal of Biological Chemistry, 1999
- Retention of Supraspinal Delta-like Analgesia and Loss of Morphine Tolerance in δ Opioid Receptor Knockout MiceNeuron, 1999
- Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometryTrends in Pharmacological Sciences, 1997
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995
- Islet Amyloid Polypeptide Stimulates Cyclic AMP Accumulation via the Porcine Calcitonin ReceptorBiochemical and Biophysical Research Communications, 1994
- δ-Opioid receptor subtypes and cross-talk with μ-receptorsTrends in Pharmacological Sciences, 1993
- Starvation of a clonal osteoblast-like cell line, MOB 3-4-F2, down-regulates prostaglandin E2 receptors but increases cAMP response to prostaglandin E2Cellular Signalling, 1991